SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3f6u'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AQ7_B_AG2B4_1 (TRYPSIN AERUGINOSIN 98-B)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	6 / 8	HIS H 57 ASP H 189 SER H 195 VAL H 213 GLY H 216 GLY H 226	0G6 H 1 (-3.2A) 0G6 H 1 (-2.8A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.73A	1aq7A-3f6uH: 34.3	1aq7A-3f6uH: 36.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	7 / 9	ASP H 189 ALA H 190 SER H 195 VAL H 213 TRP H 215 GLY H 216 GLY H 226	0G6 H 1 (-2.8A) 0G6 H 1 (-3.4A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-4.1A) 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.37A	1bcuH-3f6uH: 36.4	1bcuH-3f6uH: 40.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1DWC_H_MITH1_1 (ALPHA-THROMBIN (LARGE SUBUNIT))	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 9	HIS H 57 ASP H 189 SER H 195 TRP H 215 GLY H 226	0G6 H 1 (-3.2A) 0G6 H 1 (-2.8A) 0G6 H 1 (-1.8A) 0G6 H 1 (-4.1A) 0G6 H 1 ( 3.9A)	0.54A	1dwcH-3f6uH: 36.1	1dwcH-3f6uH: 40.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERE_E_ESTE600_1 (ESTROGEN RECEPTOR)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 8	ALA H 44 LEU H 33 LEU H 40 LEU H 68	None	0.94A	1ereE-3f6uH: undetectable	1ereE-3f6uH: 21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERE_F_ESTF600_1 (ESTROGEN RECEPTOR)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 8	ALA H 44 LEU H 33 LEU H 40 LEU H 68	None	0.95A	1ereF-3f6uH: undetectable	1ereF-3f6uH: 21.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	7 / 12	ASP H 189 GLU H 192 SER H 195 VAL H 213 TRP H 215 GLY H 216 GLY H 226	0G6 H 1 (-2.8A) 0G6 H 1 ( 4.0A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-4.1A) 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.66A	1etrH-3f6uH: 35.2	1etrH-3f6uH: 41.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	7 / 12	HIS H 57 ASP H 189 SER H 195 VAL H 213 TRP H 215 GLY H 216 GLY H 226	0G6 H 1 (-3.2A) 0G6 H 1 (-2.8A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-4.1A) 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.67A	1etrH-3f6uH: 35.2	1etrH-3f6uH: 41.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 8	ASP H 189 SER H 195 VAL H 213 GLY H 216 GLY H 226	0G6 H 1 (-2.8A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.49A	1f5lA-3f6uH: 33.1	1f5lA-3f6uH: 35.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HRK_B_CHDB2503_0 (FERROCHELATASE)	3f6u	VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN (Homo sapiens)	4 / 4	LEU L 53 PRO L 54 LEU L 55 ARG L 87	None	1.25A	1hrkB-3f6uL: undetectable	1hrkB-3f6uL: 11.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SS4_A_ACTA411_0 (GLYOXALASE FAMILY PROTEIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 5	VAL H 138 THR H 139 GLN H 30 ILE H 121	None	1.32A	1ss4A-3f6uH: undetectable	1ss4A-3f6uH: 19.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TNL_A_TPAA900_1 (TRYPSIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 6	ASP H 189 SER H 195 VAL H 213 GLY H 216 GLY H 226	0G6 H 1 (-2.8A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.40A	1tnlA-3f6uH: 35.2	1tnlA-3f6uH: 35.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YA4_C_CTXC3_1 (CES1 PROTEIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 12	GLY H 193 SER H 195 LEU H 40 LEU H 64 HIS H 57	0G6 H 1 (-4.1A) 0G6 H 1 (-1.8A) None None 0G6 H 1 (-3.2A)	0.94A	1ya4C-3f6uH: undetectable	1ya4C-3f6uH: 17.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HDN_J_TACJ5888_1 (ELONGATION FACTOR EF-TU)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 6	THR H 22 SER H 27 ASP H 26 VAL H 200	None	1.18A	2hdnI-3f6uH: undetectable 2hdnJ-3f6uH: undetectable 2hdnL-3f6uH: undetectable	2hdnI-3f6uH: 9.21 2hdnJ-3f6uH: 20.81 2hdnL-3f6uH: 20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HDN_L_TACL6888_1 (ELONGATION FACTOR EF-TU)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 6	VAL H 200 THR H 22 SER H 27 ASP H 26	None	1.24A	2hdnJ-3f6uH: undetectable 2hdnK-3f6uH: undetectable 2hdnL-3f6uH: undetectable	2hdnJ-3f6uH: 20.81 2hdnK-3f6uH: 9.21 2hdnL-3f6uH: 20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRC_A_CHDA703_0 (FERROCHELATASE)	3f6u	VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN (Homo sapiens)	4 / 4	LEU L 53 PRO L 54 LEU L 55 ARG L 87	None	1.35A	2hrcA-3f6uL: undetectable	2hrcA-3f6uL: 11.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRC_B_CHDB1604_0 (FERROCHELATASE)	3f6u	VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN (Homo sapiens)	4 / 4	LEU L 53 PRO L 54 LEU L 55 ARG L 87	None	1.24A	2hrcB-3f6uL: undetectable	2hrcB-3f6uL: 11.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_D_CLMD1142_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 5	PRO H 164 PRO H 161 ILE H 184 GLY H 184	None	1.13A	2jkjD-3f6uH: undetectable	2jkjD-3f6uH: 21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_F_CLMF1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 5	PRO H 164 PRO H 161 ILE H 184 GLY H 184	None	1.13A	2jkjF-3f6uH: undetectable	2jkjF-3f6uH: 21.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 6	ASP H 189 SER H 195 VAL H 213 GLY H 216 GLY H 226	0G6 H 1 (-2.8A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.30A	2otvA-3f6uH: 35.4	2otvA-3f6uH: 36.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_D_SAMD300_0 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	6 / 12	GLY H 142 GLY H 196 GLY H 193 THR H 54 LEU H 53 VAL H 31	None None 0G6 H 1 (-4.1A) None None None	1.22A	2oxtD-3f6uH: undetectable	2oxtD-3f6uH: 20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	8 / 12	ASP H 189 ALA H 190 SER H 195 VAL H 213 TRP H 215 GLY H 216 GLY H 226 TYR H 228	0G6 H 1 (-2.8A) 0G6 H 1 (-3.4A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-4.1A) 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A) None	0.34A	2p16A-3f6uH: 37.4	2p16A-3f6uH: 37.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PNJ_B_CHDB503_0 (FERROCHELATASE, MITOCHONDRIAL)	3f6u	VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN (Homo sapiens)	4 / 4	LEU L 53 PRO L 54 LEU L 55 ARG L 87	None	1.31A	2pnjB-3f6uL: undetectable	2pnjB-3f6uL: 11.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD2_A_CHDA426_0 (FERROCHELATASE)	3f6u	VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN (Homo sapiens)	4 / 4	LEU L 53 PRO L 54 LEU L 55 ARG L 87	None	1.46A	2qd2A-3f6uL: undetectable	2qd2A-3f6uL: 11.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD4_A_CHDA803_0 (FERROCHELATASE)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 5	LEU H 123 PRO H 124 LEU H 235 ILE H 238	None	0.80A	2qd4A-3f6uH: undetectable	2qd4A-3f6uH: 21.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VIN_A_505A1247_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 8	ASP H 189 SER H 195 VAL H 213 GLY H 216 GLY H 226	0G6 H 1 (-2.8A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.48A	2vinA-3f6uH: 33.3	2vinA-3f6uH: 35.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	9 / 12	ASP H 189 ALA H 190 SER H 195 VAL H 213 TRP H 215 GLY H 216 GLY H 219 GLY H 226 TYR H 228	0G6 H 1 (-2.8A) 0G6 H 1 (-3.4A) 0G6 H 1 (-1.8A) None 0G6 H 1 (-4.1A) 0G6 H 1 (-3.8A) None 0G6 H 1 ( 3.9A) None	0.51A	2w26A-3f6uH: 37.3	2w26A-3f6uH: 37.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GY3_A_PNTA246_0 (CATIONIC TRYPSIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	6 / 11	HIS H 57 ASP H 189 SER H 195 TRP H 215 GLY H 216 GLY H 226	0G6 H 1 (-3.2A) 0G6 H 1 (-2.8A) 0G6 H 1 (-1.8A) 0G6 H 1 (-4.1A) 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.56A	3gy3A-3f6uH: 33.8	3gy3A-3f6uH: 36.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HCO_B_CHDB1_0 (FERROCHELATASE, MITOCHONDRIAL)	3f6u	VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN (Homo sapiens)	4 / 4	LEU L 53 PRO L 54 LEU L 55 ARG L 87	None	1.27A	3hcoB-3f6uL: undetectable	3hcoB-3f6uL: 11.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP4_A_MIIA2001_1 (TRANSCRIPTIONAL REGULATOR TCAR)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 9	ASN H 179 THR H 229 LEU H 212 ALA H 56 HIS H 91	None	1.30A	3kp4A-3f6uH: undetectable 3kp4B-3f6uH: undetectable	3kp4A-3f6uH: 20.25 3kp4B-3f6uH: 20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LOQ_A_ACTA277_0 (UNIVERSAL STRESS PROTEIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	3 / 3	ASP H 100 SER H 177 ARG H 233	None	1.01A	3loqA-3f6uH: undetectable	3loqA-3f6uH: 21.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 6	SER H 195 VAL H 213 TRP H 215 GLY H 216 GLY H 226	0G6 H 1 (-1.8A) None 0G6 H 1 (-4.1A) 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.41A	3rxfA-3f6uH: 12.7	3rxfA-3f6uH: 36.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXH_A_HSMA7_1 (CATIONIC TRYPSIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 5	ASP H 189 SER H 195 VAL H 213 GLY H 226	0G6 H 1 (-2.8A) 0G6 H 1 (-1.8A) None 0G6 H 1 ( 3.9A)	0.45A	3rxhA-3f6uH: 35.1	3rxhA-3f6uH: 36.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EJW_A_SRYA2001_1 (TRANSCRIPTIONAL REGULATOR TCAR)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 12	ASN H 179 THR H 229 LEU H 212 ALA H 56 HIS H 91	None	1.33A	4ejwA-3f6uH: undetectable	4ejwA-3f6uH: 20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F4D_B_CHDB504_0 (FERROCHELATASE, MITOCHONDRIAL)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 4	LEU H 123 PRO H 124 LEU H 235 ILE H 238	None	0.88A	4f4dB-3f6uH: undetectable	4f4dB-3f6uH: 21.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HFP_B_15UB402_1 (PROTHROMBIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 12	HIS H 57 ASP H 189 GLU H 192 GLY H 216 GLY H 226	0G6 H 1 (-3.2A) 0G6 H 1 (-2.8A) 0G6 H 1 ( 4.0A) 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.63A	4hfpB-3f6uH: 35.4	4hfpB-3f6uH: 39.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HFP_D_15UD402_1 (PROTHROMBIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	6 / 12	ASP H 189 ALA H 190 GLU H 192 VAL H 213 TRP H 215 GLY H 226	0G6 H 1 (-2.8A) 0G6 H 1 (-3.4A) 0G6 H 1 ( 4.0A) None 0G6 H 1 (-4.1A) 0G6 H 1 ( 3.9A)	0.74A	4hfpD-3f6uH: 35.4	4hfpD-3f6uH: 39.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HFP_D_15UD402_1 (PROTHROMBIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	6 / 12	HIS H 57 ASP H 189 ALA H 190 VAL H 213 TRP H 215 GLY H 226	0G6 H 1 (-3.2A) 0G6 H 1 (-2.8A) 0G6 H 1 (-3.4A) None 0G6 H 1 (-4.1A) 0G6 H 1 ( 3.9A)	0.38A	4hfpD-3f6uH: 35.4	4hfpD-3f6uH: 39.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JX1_F_CAMF502_0 (CAMPHOR 5-MONOOXYGENASE)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 4	TYR H 228 THR H 139 VAL H 200 ILE H 160	None	1.19A	4jx1F-3f6uH: undetectable	4jx1F-3f6uH: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	6 / 10	ALA H 55 THR H 54 ALA H 104 ALA H 56 GLY H 211 THR H 229	None	1.45A	4qvyK-3f6uH: undetectable 4qvyL-3f6uH: undetectable	4qvyK-3f6uH: 23.62 4qvyL-3f6uH: 20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	6 / 10	ALA H 55 THR H 54 ALA H 104 ALA H 56 GLY H 211 THR H 229	None	1.45A	4qvyY-3f6uH: undetectable 4qvyZ-3f6uH: undetectable	4qvyY-3f6uH: 23.62 4qvyZ-3f6uH: 20.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	6 / 12	HIS H 57 ALA H 190 VAL H 213 TRP H 215 GLY H 216 GLY H 226	0G6 H 1 (-3.2A) 0G6 H 1 (-3.4A) None 0G6 H 1 (-4.1A) 0G6 H 1 (-3.8A) 0G6 H 1 ( 3.9A)	0.91A	4rn6B-3f6uH: 30.6	4rn6B-3f6uH: 36.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AXD_C_RBVC502_2 (ADENOSYLHOMOCYSTEINA SE)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	3 / 3	THR H 229 HIS H 48 LEU H 123	None	0.85A	5axdC-3f6uH: undetectable	5axdC-3f6uH: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESH_A_1YNA602_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 5	TRP H 29 LEU H 212 PRO H 198 LEU H 106	None	1.09A	5eshA-3f6uH: undetectable	5eshA-3f6uH: 17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_C_CVIC301_1 (REGULATORY PROTEIN TETR)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	4 / 7	GLY H 226 ILE H 158 GLN H 30 ASP H 194	0G6 H 1 ( 3.9A) None None None	0.98A	5vlmC-3f6uH: undetectable	5vlmC-3f6uH: 20.69

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AQ7_B_AG2B4_1","TRYPSIN;AERUGINOSIN 98-B","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",6,"HIS H  57;ASP H 189;SER H 195;VAL H 213;GLY H 216;GLY H 226","0G6 H   1 (-3.2A);0G6 H   1 (-2.8A);0G6 H   1 (-1.8A);None;0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.73A","1aq7A-3f6uH:34.3","1aq7A-3f6uH:36.67"],["1BCU_H_PRLH280_0","ALPHA-THROMBIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",7,"ASP H 189;ALA H 190;SER H 195;VAL H 213;TRP H 215;GLY H 216;GLY H 226","0G6 H   1 (-2.8A);0G6 H   1 (-3.4A);0G6 H   1 (-1.8A);None;0G6 H   1 (-4.1A);0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.37A","1bcuH-3f6uH:36.4","1bcuH-3f6uH:40.23"],["1DWC_H_MITH1_1","ALPHA-THROMBIN (LARGE SUBUNIT)","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"HIS H  57;ASP H 189;SER H 195;TRP H 215;GLY H 226","0G6 H   1 (-3.2A);0G6 H   1 (-2.8A);0G6 H   1 (-1.8A);0G6 H   1 (-4.1A);0G6 H   1 ( 3.9A)","0.54A","1dwcH-3f6uH:36.1","1dwcH-3f6uH:40.23"],["1ERE_E_ESTE600_1","ESTROGEN RECEPTOR","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"ALA H  44;LEU H  33;LEU H  40;LEU H  68","None","0.94A","1ereE-3f6uH:undetectable","1ereE-3f6uH:21.94"],["1ERE_F_ESTF600_1","ESTROGEN RECEPTOR","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"ALA H  44;LEU H  33;LEU H  40;LEU H  68","None","0.95A","1ereF-3f6uH:undetectable","1ereF-3f6uH:21.94"],["1ETR_H_MITH1_1","EPSILON-THROMBIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",7,"ASP H 189;GLU H 192;SER H 195;VAL H 213;TRP H 215;GLY H 216;GLY H 226","0G6 H   1 (-2.8A);0G6 H   1 ( 4.0A);0G6 H   1 (-1.8A);None;0G6 H   1 (-4.1A);0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.66A","1etrH-3f6uH:35.2","1etrH-3f6uH:41.15"],["1ETR_H_MITH1_1","EPSILON-THROMBIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",7,"HIS H  57;ASP H 189;SER H 195;VAL H 213;TRP H 215;GLY H 216;GLY H 226","0G6 H   1 (-3.2A);0G6 H   1 (-2.8A);0G6 H   1 (-1.8A);None;0G6 H   1 (-4.1A);0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.67A","1etrH-3f6uH:35.2","1etrH-3f6uH:41.15"],["1F5L_A_AMRA301_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"ASP H 189;SER H 195;VAL H 213;GLY H 216;GLY H 226","0G6 H   1 (-2.8A);0G6 H   1 (-1.8A);None;0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.49A","1f5lA-3f6uH:33.1","1f5lA-3f6uH:35.82"],["1HRK_B_CHDB2503_0","FERROCHELATASE","3f6u","VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN","Homo sapiens",4,"LEU L  53;PRO L  54;LEU L  55;ARG L  87","None","1.25A","1hrkB-3f6uL:undetectable","1hrkB-3f6uL:11.68"],["1SS4_A_ACTA411_0","GLYOXALASE FAMILY PROTEIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"VAL H 138;THR H 139;GLN H  30;ILE H 121","None","1.32A","1ss4A-3f6uH:undetectable","1ss4A-3f6uH:19.51"],["1TNL_A_TPAA900_1","TRYPSIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"ASP H 189;SER H 195;VAL H 213;GLY H 216;GLY H 226","0G6 H   1 (-2.8A);0G6 H   1 (-1.8A);None;0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.40A","1tnlA-3f6uH:35.2","1tnlA-3f6uH:35.92"],["1YA4_C_CTXC3_1","CES1 PROTEIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"GLY H 193;SER H 195;LEU H  40;LEU H  64;HIS H  57","0G6 H   1 (-4.1A);0G6 H   1 (-1.8A);None;None;0G6 H   1 (-3.2A)","0.94A","1ya4C-3f6uH:undetectable","1ya4C-3f6uH:17.96"],["2HDN_J_TACJ5888_1","ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"THR H  22;SER H  27;ASP H  26;VAL H 200","None","1.18A","2hdnI-3f6uH:undetectable;2hdnJ-3f6uH:undetectable;2hdnL-3f6uH:undetectable","2hdnI-3f6uH:9.21;2hdnJ-3f6uH:20.81;2hdnL-3f6uH:20.81"],["2HDN_L_TACL6888_1","ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"VAL H 200;THR H  22;SER H  27;ASP H  26","None","1.24A","2hdnJ-3f6uH:undetectable;2hdnK-3f6uH:undetectable;2hdnL-3f6uH:undetectable","2hdnJ-3f6uH:20.81;2hdnK-3f6uH:9.21;2hdnL-3f6uH:20.81"],["2HRC_A_CHDA703_0","FERROCHELATASE","3f6u","VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN","Homo sapiens",4,"LEU L  53;PRO L  54;LEU L  55;ARG L  87","None","1.35A","2hrcA-3f6uL:undetectable","2hrcA-3f6uL:11.68"],["2HRC_B_CHDB1604_0","FERROCHELATASE","3f6u","VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN","Homo sapiens",4,"LEU L  53;PRO L  54;LEU L  55;ARG L  87","None","1.24A","2hrcB-3f6uL:undetectable","2hrcB-3f6uL:11.68"],["2JKJ_D_CLMD1142_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"PRO H 164;PRO H 161;ILE H 184;GLY H 184","None","1.13A","2jkjD-3f6uH:undetectable","2jkjD-3f6uH:21.07"],["2JKJ_F_CLMF1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"PRO H 164;PRO H 161;ILE H 184;GLY H 184","None","1.13A","2jkjF-3f6uH:undetectable","2jkjF-3f6uH:21.07"],["2OTV_A_NCAA1301_0","CATIONIC TRYPSIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"ASP H 189;SER H 195;VAL H 213;GLY H 216;GLY H 226","0G6 H   1 (-2.8A);0G6 H   1 (-1.8A);None;0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.30A","2otvA-3f6uH:35.4","2otvA-3f6uH:36.67"],["2OXT_D_SAMD300_0","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",6,"GLY H 142;GLY H 196;GLY H 193;THR H  54;LEU H  53;VAL H  31","None;None;0G6 H   1 (-4.1A);None;None;None","1.22A","2oxtD-3f6uH:undetectable","2oxtD-3f6uH:20.00"],["2P16_A_GG2A298_1","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",8,"ASP H 189;ALA H 190;SER H 195;VAL H 213;TRP H 215;GLY H 216;GLY H 226;TYR H 228","0G6 H   1 (-2.8A);0G6 H   1 (-3.4A);0G6 H   1 (-1.8A);None;0G6 H   1 (-4.1A);0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A);None","0.34A","2p16A-3f6uH:37.4","2p16A-3f6uH:37.45"],["2PNJ_B_CHDB503_0","FERROCHELATASE, MITOCHONDRIAL","3f6u","VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN","Homo sapiens",4,"LEU L  53;PRO L  54;LEU L  55;ARG L  87","None","1.31A","2pnjB-3f6uL:undetectable","2pnjB-3f6uL:11.68"],["2QD2_A_CHDA426_0","FERROCHELATASE","3f6u","VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN","Homo sapiens",4,"LEU L  53;PRO L  54;LEU L  55;ARG L  87","None","1.46A","2qd2A-3f6uL:undetectable","2qd2A-3f6uL:11.68"],["2QD4_A_CHDA803_0","FERROCHELATASE","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"LEU H 123;PRO H 124;LEU H 235;ILE H 238","None","0.80A","2qd4A-3f6uH:undetectable","2qd4A-3f6uH:21.69"],["2VIN_A_505A1247_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"ASP H 189;SER H 195;VAL H 213;GLY H 216;GLY H 226","0G6 H   1 (-2.8A);0G6 H   1 (-1.8A);None;0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.48A","2vinA-3f6uH:33.3","2vinA-3f6uH:35.82"],["2W26_A_RIVA1001_1","ACTIVATED FACTOR XA HEAVY CHAIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",9,"ASP H 189;ALA H 190;SER H 195;VAL H 213;TRP H 215;GLY H 216;GLY H 219;GLY H 226;TYR H 228","0G6 H   1 (-2.8A);0G6 H   1 (-3.4A);0G6 H   1 (-1.8A);None;0G6 H   1 (-4.1A);0G6 H   1 (-3.8A);None;0G6 H   1 ( 3.9A);None","0.51A","2w26A-3f6uH:37.3","2w26A-3f6uH:37.45"],["3GY3_A_PNTA246_0","CATIONIC TRYPSIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",6,"HIS H  57;ASP H 189;SER H 195;TRP H 215;GLY H 216;GLY H 226","0G6 H   1 (-3.2A);0G6 H   1 (-2.8A);0G6 H   1 (-1.8A);0G6 H   1 (-4.1A);0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.56A","3gy3A-3f6uH:33.8","3gy3A-3f6uH:36.67"],["3HCO_B_CHDB1_0","FERROCHELATASE, MITOCHONDRIAL","3f6u","VITAMIN K-DEPENDENT PROTEIN C LIGHT CHAIN","Homo sapiens",4,"LEU L  53;PRO L  54;LEU L  55;ARG L  87","None","1.27A","3hcoB-3f6uL:undetectable","3hcoB-3f6uL:11.68"],["3KP4_A_MIIA2001_1","TRANSCRIPTIONAL REGULATOR TCAR;TRANSCRIPTIONAL REGULATOR TCAR","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"ASN H 179;THR H 229;LEU H 212;ALA H  56;HIS H  91","None","1.30A","3kp4A-3f6uH:undetectable;3kp4B-3f6uH:undetectable","3kp4A-3f6uH:20.25;3kp4B-3f6uH:20.25"],["3LOQ_A_ACTA277_0","UNIVERSAL STRESS PROTEIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",3,"ASP H 100;SER H 177;ARG H 233","None","1.01A","3loqA-3f6uH:undetectable","3loqA-3f6uH:21.90"],["3RXF_A_4APA9_1","CATIONIC TRYPSIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"SER H 195;VAL H 213;TRP H 215;GLY H 216;GLY H 226","0G6 H   1 (-1.8A);None;0G6 H   1 (-4.1A);0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.41A","3rxfA-3f6uH:12.7","3rxfA-3f6uH:36.67"],["3RXH_A_HSMA7_1","CATIONIC TRYPSIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"ASP H 189;SER H 195;VAL H 213;GLY H 226","0G6 H   1 (-2.8A);0G6 H   1 (-1.8A);None;0G6 H   1 ( 3.9A)","0.45A","3rxhA-3f6uH:35.1","3rxhA-3f6uH:36.67"],["4EJW_A_SRYA2001_1","TRANSCRIPTIONAL REGULATOR TCAR","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"ASN H 179;THR H 229;LEU H 212;ALA H  56;HIS H  91","None","1.33A","4ejwA-3f6uH:undetectable","4ejwA-3f6uH:20.25"],["4F4D_B_CHDB504_0","FERROCHELATASE, MITOCHONDRIAL","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"LEU H 123;PRO H 124;LEU H 235;ILE H 238","None","0.88A","4f4dB-3f6uH:undetectable","4f4dB-3f6uH:21.69"],["4HFP_B_15UB402_1","PROTHROMBIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",5,"HIS H  57;ASP H 189;GLU H 192;GLY H 216;GLY H 226","0G6 H   1 (-3.2A);0G6 H   1 (-2.8A);0G6 H   1 ( 4.0A);0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.63A","4hfpB-3f6uH:35.4","4hfpB-3f6uH:39.85"],["4HFP_D_15UD402_1","PROTHROMBIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",6,"ASP H 189;ALA H 190;GLU H 192;VAL H 213;TRP H 215;GLY H 226","0G6 H   1 (-2.8A);0G6 H   1 (-3.4A);0G6 H   1 ( 4.0A);None;0G6 H   1 (-4.1A);0G6 H   1 ( 3.9A)","0.74A","4hfpD-3f6uH:35.4","4hfpD-3f6uH:39.85"],["4HFP_D_15UD402_1","PROTHROMBIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",6,"HIS H  57;ASP H 189;ALA H 190;VAL H 213;TRP H 215;GLY H 226","0G6 H   1 (-3.2A);0G6 H   1 (-2.8A);0G6 H   1 (-3.4A);None;0G6 H   1 (-4.1A);0G6 H   1 ( 3.9A)","0.38A","4hfpD-3f6uH:35.4","4hfpD-3f6uH:39.85"],["4JX1_F_CAMF502_0","CAMPHOR 5-MONOOXYGENASE","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"TYR H 228;THR H 139;VAL H 200;ILE H 160","None","1.19A","4jx1F-3f6uH:undetectable","4jx1F-3f6uH:19.00"],["4QVY_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",6,"ALA H  55;THR H  54;ALA H 104;ALA H  56;GLY H 211;THR H 229","None","1.45A","4qvyK-3f6uH:undetectable;4qvyL-3f6uH:undetectable","4qvyK-3f6uH:23.62;4qvyL-3f6uH:20.45"],["4QVY_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",6,"ALA H  55;THR H  54;ALA H 104;ALA H  56;GLY H 211;THR H 229","None","1.45A","4qvyY-3f6uH:undetectable;4qvyZ-3f6uH:undetectable","4qvyY-3f6uH:23.62;4qvyZ-3f6uH:20.45"],["4RN6_B_15UB301_1","THROMBIN HEAVY CHAIN","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",6,"HIS H  57;ALA H 190;VAL H 213;TRP H 215;GLY H 216;GLY H 226","0G6 H   1 (-3.2A);0G6 H   1 (-3.4A);None;0G6 H   1 (-4.1A);0G6 H   1 (-3.8A);0G6 H   1 ( 3.9A)","0.91A","4rn6B-3f6uH:30.6","4rn6B-3f6uH:36.99"],["5AXD_C_RBVC502_2","ADENOSYLHOMOCYSTEINASE","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",3,"THR H 229;HIS H  48;LEU H 123","None","0.85A","5axdC-3f6uH:undetectable","5axdC-3f6uH:20.77"],["5ESH_A_1YNA602_2","LANOSTEROL 14-ALPHA DEMETHYLASE","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"TRP H  29;LEU H 212;PRO H 198;LEU H 106","None","1.09A","5eshA-3f6uH:undetectable","5eshA-3f6uH:17.83"],["5VLM_C_CVIC301_1","REGULATORY PROTEIN TETR","3f6u","VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN","Homo sapiens",4,"GLY H 226;ILE H 158;GLN H  30;ASP H 194","0G6 H   1 ( 3.9A);None;None;None","0.98A","5vlmC-3f6uH:undetectable","5vlmC-3f6uH:20.69"]]